In this cohort study researchers found that greater chronic kidney disease (CKD) severity—particularly higher urinary albumin to creatinine ratio—was independently associated with increased risk of incident cognitive impairment among adults with CKD. The findings suggest that albuminuria may serve as a clinically useful marker to identify patients at elevated risk for cognitive decline, reinforcing the importance of vascular and metabolic risk optimization in CKD management.

Source: JAMA Network Open